Cargando…

Olfactory marker protein regulation of glucagon secretion in hyperglycemia

The olfactory marker protein (OMP), which is also expressed in nonolfactory tissues, plays a role in regulating the kinetics and termination of olfactory transduction. Thus, we hypothesized that OMP may play a similar role in modulating the secretion of hormones involved in Ca(2+) and cAMP signaling...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Ju Hun, Han, Ye Eon, Bao, Ya Ru, Kang, Chan Woo, Koo, JaeHyung, Ku, Cheol Ryong, Cho, Yoon Hee, Lee, Eun Jig
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534918/ https://www.ncbi.nlm.nih.gov/pubmed/36104518 http://dx.doi.org/10.1038/s12276-022-00843-8

Ejemplares similares

Olfactory marker protein regulates prolactin secretion and production by modulating Ca(2+) and TRH signaling in lactotrophs
por: Kang, Chan Woo, et al.
Publicado: (2018)

Olfactory Marker Protein Expression Is an Indicator of Olfactory Receptor-Associated Events in Non-Olfactory Tissues
por: Kang, NaNa, et al.
Publicado: (2015)

Olfactory Receptor OR51E1 Mediates GLP-1 Secretion in Human and Rodent Enteroendocrine L Cells
por: Han, Ye Eon, et al.
Publicado: (2018)

Acetate-Mediated Odorant Receptor OR51E2 Activation Results in Calcitonin Secretion in Parafollicular C-Cells: A Novel Diagnostic Target of Human Medullary Thyroid Cancer
por: Lee, Hyeon Jeong, et al.
Publicado: (2023)

SAT648 The Role Of Olfactory Marker Protein On Adipogenesis
por: Bao, Yaru, et al.
Publicado: (2023)

Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas
por: Kim, Jean, et al.
Publicado: (2020)

Olfactory receptors in non-chemosensory tissues
por: Kang, NaNa, et al.
Publicado: (2012)

SAT031 The Effect Of Metformin On Increasing Glucose Metabolism And Secretion In The Distal Intestine
por: Ho Nam, Jung, et al.
Publicado: (2023)

THU553 Anti-tumor Effect Of Rosiglitazone Via Upregulating 15-PDGH In Prolactin Secreting Adenoma
por: Kang, Chan Woo, et al.
Publicado: (2023)

SUN-115 Role of Olfactory Marker Protein in High-Fat, Diet-Induced Obese Models
por: Oh, Ju Hun, et al.
Publicado: (2019)

Activation of intestinal olfactory receptor stimulates glucagon-like peptide-1 secretion in enteroendocrine cells and attenuates hyperglycemia in type 2 diabetic mice
por: Kim, Ki-Suk, et al.
Publicado: (2017)

Sitagliptin Improves Postprandial Hyperglycemia by Inhibiting Glucagon Secretion in Werner Syndrome With Diabetes
por: Watanabe, Kaneyuki, et al.
Publicado: (2013)

Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production
por: Knudsen, Jakob G., et al.
Publicado: (2019)

Dexamethasone suppression for (18)F-FDG PET/CT to localize ACTH-secreting pituitary tumors
por: Kim, Kyungwon, et al.
Publicado: (2023)

Interhemispheric asymmetry of c‐Fos expression in glomeruli and the olfactory tubercle following repeated odor stimulation
por: Jae, YoonGyu, et al.
Publicado: (2020)

Associations of GNAS Mutations with Surgical Outcomes in Patients with Growth Hormone-Secreting Pituitary Adenoma
por: Jung, Hyein, et al.
Publicado: (2021)

Response: The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown Adipocytes (Endocrinol Metab 2016;31:328-35, Cheol Ryong Ku et al.)
por: Ku, Cheol Ryong, et al.
Publicado: (2016)

Somatotroph-Specific Aip-Deficient Mice Display Pretumorigenic Alterations in Cell-Cycle Signaling
por: Gillam, Mary P., et al.
Publicado: (2017)

Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine
por: Kim, Kyungwon, et al.
Publicado: (2023)

The aglycone of ginsenoside Rg3 enables glucagon-like peptide-1 secretion in enteroendocrine cells and alleviates hyperglycemia in type 2 diabetic mice
por: Kim, Ki-Suk, et al.
Publicado: (2015)

MON-LB080 Change of T2-Weighted Intensity of Prolactinoma as a Predictable Value for Relapse of Hyperprolactinemia after Cabergoline Withdrawal
por: Kim, Kyungwon, et al.
Publicado: (2019)

Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality?
por: Ku, Cheol Ryong, et al.
Publicado: (2020)

THU483 Role Of Excess GH On Breast Cancer Aggressiveness And Metastasis In Acromegaly
por: Hun, Ju, et al.
Publicado: (2023)

Berberine Attenuates Hyperglycemia by Inhibiting the Hepatic Glucagon Pathway in Diabetic Mice
por: Zhong, Ying, et al.
Publicado: (2020)

FRI533 A Novel Cre-loxP Based Mouse Model For Graves' Disease
por: Kim, Daham, et al.
Publicado: (2023)

Danshen Extracts Prevents Obesity and Activates Mitochondrial Function in Brown Adipose Tissue
por: Cho, Yoon Hee, et al.
Publicado: (2021)

Altered Glucose Metabolism and Glucose Transporters in Systemic Organs After Bariatric Surgery
por: Oh, Ju Hun, et al.
Publicado: (2022)

Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia
por: Tan, Tricia M., et al.
Publicado: (2013)

Novel somatic variants involved in biochemical activity of pure growth hormone-secreting pituitary adenoma without GNAS variant
por: Ku, Cheol Ryong, et al.
Publicado: (2021)

Characteristics of Acromegaly in Korea with a Literature Review
por: Hong, Jae Won, et al.
Publicado: (2013)

Antidiabetic Effects of NRDT50, the Enzyme Composition for Regulating Sugar Metabolism, in Db/db Mice
por: Kim, Daham, et al.
Publicado: (2021)

Glucagon secretion and signaling in the development of diabetes
por: Gaisano, Herbert Y., et al.
Publicado: (2012)

Regulating Glucagon Secretion: Somatostatin in the Spotlight
por: Rutter, Guy A.
Publicado: (2009)

Mechanisms of the Regulation and Dysregulation of Glucagon Secretion
por: Onyango, Arnold N.
Publicado: (2020)

Neuronal regulation of glucagon secretion and gluconeogenesis
por: Thorens, Bernard
Publicado: (2022)

γ-Hydroxybutyrate does not mediate glucose inhibition of glucagon secretion
por: Yu, Qian, et al.
Publicado: (2020)

SAT-436 Adjuvant Therapeutic Modalities in Acromegaly: Clinical Course and Factors Predicting Biochemical Controls
por: Jung, Hyein, et al.
Publicado: (2019)

Clinical Significance of Radical Surgery in the Treatment of Silent Corticotroph Adenoma
por: Kim, Junhyung, et al.
Publicado: (2019)

THU072 Association Between Nonalcoholic Fatty Liver Disease And Growth Hormone Deficiency In Patients With Nonfunctioning Pituitary Adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jjccll3t4hs8jvb69taakji89v